Go Pro

Odyssean LLC Has $2.77 Million Stock Position in Medical Properties Trust, Inc. $MPT

Medical Properties Trust logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Odyssean LLC increased its Medical Properties Trust stake by 133.8% in the second quarter, holding 599,358 shares worth approximately $2.77 million. Institutional investors and hedge funds collectively own 71.79% of MPT.
  • Analyst sentiment remains cautious: MPT has an average rating of “Reduce” and an average price target of $4.50, while shares recently traded at $4.11 within a 12-month range of $3.96 to $6.47.
  • MPT reported quarterly earnings of $0.15 per share, matching estimates, with revenue rising 7.9% year over year to $259.28 million. The company declared a $0.09 quarterly dividend, equivalent to an 8.8% annualized yield.
  • MarketBeat previews top five stocks to own in October.

Odyssean LLC raised its stake in Medical Properties Trust, Inc. (NYSE:MPT - Free Report) by 133.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 599,358 shares of the company's stock after acquiring an additional 343,015 shares during the quarter. Odyssean LLC owned about 0.10% of Medical Properties Trust worth $2,769,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of the stock. OneAscent Family Office LLC acquired a new position in shares of Medical Properties Trust in the second quarter valued at approximately $49,000. Greenspring Advisors LLC acquired a new stake in Medical Properties Trust during the 2nd quarter worth approximately $54,000. Callan Family Office LLC acquired a new stake in Medical Properties Trust during the 2nd quarter worth approximately $66,000. Allworth Financial LP acquired a new stake in Medical Properties Trust during the 2nd quarter worth approximately $76,000. Finally, Sanctuary Advisors LLC bought a new stake in Medical Properties Trust in the 2nd quarter valued at $81,000. 71.79% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

MPT has been the topic of a number of research reports. Weiss Ratings lowered Medical Properties Trust from a "sell (d+)" rating to a "sell (d)" rating in a report on Tuesday, August 18th. Royal Bank Of Canada dropped their target price on Medical Properties Trust from $5.00 to $4.50 and set a "sector perform" rating for the company in a report on Thursday, June 18th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of "Reduce" and an average target price of $4.50.

Get Our Latest Stock Analysis on MPT

Medical Properties Trust Trading Down 0.2%

Shares of MPT opened at $4.11 on Wednesday. Medical Properties Trust, Inc. has a 12 month low of $3.96 and a 12 month high of $6.47. The stock's 50 day simple moving average is $4.51. The company has a market capitalization of $2.45 billion, a PE ratio of -68.50 and a beta of 1.41. The company has a debt-to-equity ratio of 2.16, a current ratio of 3.12 and a quick ratio of 3.12.

Medical Properties Trust (NYSE:MPT - Get Free Report) last released its quarterly earnings results on Monday, August 10th. The company reported $0.15 earnings per share for the quarter, meeting analysts' consensus estimates of $0.15. The company had revenue of $259.28 million during the quarter. Medical Properties Trust had a negative net margin of 2.96% and a negative return on equity of 0.66%. The company's revenue for the quarter was up 7.9% compared to the same quarter last year. Equities research analysts predict that Medical Properties Trust, Inc. will post 0.6 earnings per share for the current fiscal year.

Medical Properties Trust Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 8th. Shareholders of record on Thursday, September 10th will be issued a $0.09 dividend. The ex-dividend date of this dividend is Thursday, September 10th. This represents a $0.36 annualized dividend and a yield of 8.8%. Medical Properties Trust's payout ratio is currently -600.00%.

Medical Properties Trust Company Profile

(Free Report)

Medical Properties Trust, Inc NYSE: MPT is a real estate investment trust (REIT) that acquires, owns and finances hospitals and other healthcare facilities. Founded in 2003 by Edward K. Aldag Jr., the company’s business model centers on providing real estate capital to healthcare operators through long-term leases, sale-leaseback transactions, build-to-suit developments and mortgage financing. By specializing in healthcare real estate, MPT aims to deliver steady rental income and asset-based returns while enabling operators to access capital for clinical operations and growth.

The company’s portfolio primarily comprises acute care hospitals, inpatient rehabilitation hospitals, long-term acute care facilities, behavioral health centers and other specialty hospitals.

Featured Articles

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines